Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals.
Libertone R, Lorenzini P, Balestra P, Pinnetti C, Ricottini M, Plazzi MM, Menichetti S, Zaccarelli M, Nicastri E, Bellagamba R, Ammassari A, Antinori A. Libertone R, et al. Among authors: balestra p. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19655. doi: 10.7448/IAS.17.4.19655. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394159 Free PMC article.
Neurocognitive performance and quality of life in patients with HIV infection.
Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW. Tozzi V, et al. Among authors: balestra p. AIDS Res Hum Retroviruses. 2003 Aug;19(8):643-52. doi: 10.1089/088922203322280856. AIDS Res Hum Retroviruses. 2003. PMID: 13678465
Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.
Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P. Tozzi V, et al. Among authors: balestra p. J Neurovirol. 2005 Jul;11(3):265-73. doi: 10.1080/13550280590952790. J Neurovirol. 2005. PMID: 16036806
Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.
Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P. Tozzi V, et al. Among authors: balestra p. AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13. doi: 10.1089/aid.2005.21.706. AIDS Res Hum Retroviruses. 2005. PMID: 16131310
Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy.
Giancola ML, Lorenzini P, Balestra P, Larussa D, Baldini F, Corpolongo A, Narciso P, Bellagamba R, Tozzi V, Antinori A. Giancola ML, et al. Among authors: balestra p. J Acquir Immune Defic Syndr. 2006 Mar;41(3):332-7. doi: 10.1097/01.qai.0000197077.64021.07. J Acquir Immune Defic Syndr. 2006. PMID: 16540934
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.
Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P. Tozzi V, et al. Among authors: balestra p. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82. doi: 10.1097/QAI.0b013e318042e1ee. J Acquir Immune Defic Syndr. 2007. PMID: 17356465
Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A. Tozzi V, et al. Among authors: balestra p. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63. doi: 10.1097/qai.0b013e3181af83d6. J Acquir Immune Defic Syndr. 2009. PMID: 19731418
Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.
Haddow LJ, Laverick R, Daskalopoulou M, McDonnell J, Lampe FC, Gilson R, Speakman A, Antinori A, Balestra P, Bruun T, Gerstoft J, Nielsen L, Vassilenko A, Collins S, Rodger AJ; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group. Haddow LJ, et al. Among authors: balestra p. AIDS Behav. 2018 May;22(5):1573-1583. doi: 10.1007/s10461-017-1683-z. AIDS Behav. 2018. PMID: 28144792 Free PMC article.
Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment.
Giancola ML, Balestra P, Ammassari A, Ricottini M, Lorenzini P, Angeletti C, Bellagamba R, Tommasi C, Tempestilli M, Zaccarelli M, Pinnetti C, Gallo AL, Antinori A, Narciso P, Nicastri E. Giancola ML, et al. Among authors: balestra p. AIDS Res Hum Retroviruses. 2018 Nov;34(11):907-908. doi: 10.1089/AID.2018.0074. Epub 2018 Jul 23. AIDS Res Hum Retroviruses. 2018. PMID: 29929374 No abstract available.
30 results